All In MedTech

FDA Clearance Tracker · P000040-S014

GENESYS HTA SYSTEM

A PMA supplement is a change to a device that already has premarket approval, such as a new indication, a design change or a manufacturing change.

Last checked: Nov 20, 2026Latest source record: Apr 23, 2010 (this decision)Source: openFDAMethods & limitations

PMA supplement

The decision

FDA number
P000040-S014
Device name
GENESYS HTA SYSTEM
Applicant location
Jacksonville, FL
Received
May 6, 2009
Decided
Apr 23, 2010
Decision
Approved
Supplement type
Normal 180 Day Track
Reason for supplement
Change Design/Components/Specifications/Material
Original approval
P000040

Device type

Device class
Class III

Every decision under product code MNB

FDA's approval statement

As written in FDA's record.

APPROVAL FOR THE ¿NEXT GENERATION¿ HTA SYSTEM WITH A REDESIGNED OPERATIONAL UNIT (CONTROL UNIT, POWER CORD, PEDESTAL, IV POLE) AND A MODIFIED STERILE PROCEDURE SET. THE DEVICE, AS MODIFIED, WILL BE MARKETED UNDER THE TRADE NAME GENESYS HTA SYSTEM AND IS INDICATED FOR ABLATION OF THE ENDOMETRIAL LINING OF THE UTERUS IN PREMENOPAUSAL WOMEN WITH MENORRHAGIA (EXCESSIVE UTERINE BLEEDING) DUE TO BENIGN CAUSES FOR WHOM CHILDBEARING IS COMPLETE.

Source documents

Other decisions for Axora Medical, Inc.

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

1 more FDA decisions with a free account

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.